NO20021950D0 - Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid - Google Patents

Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid

Info

Publication number
NO20021950D0
NO20021950D0 NO20021950A NO20021950A NO20021950D0 NO 20021950 D0 NO20021950 D0 NO 20021950D0 NO 20021950 A NO20021950 A NO 20021950A NO 20021950 A NO20021950 A NO 20021950A NO 20021950 D0 NO20021950 D0 NO 20021950D0
Authority
NO
Norway
Prior art keywords
methylbenzoyl
preparation
methanesulfonyl
bis
guanidine hydrochloride
Prior art date
Application number
NO20021950A
Other languages
English (en)
Other versions
NO20021950L (no
NO328250B1 (no
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021950D0 publication Critical patent/NO20021950D0/no
Publication of NO20021950L publication Critical patent/NO20021950L/no
Publication of NO328250B1 publication Critical patent/NO328250B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021950A 1999-10-26 2002-04-25 Fremgangsmate for fremstilling av N-(4,5-bis-metansulfonyl-2-metylbenzoyl)-guanidin-hydroklorid NO328250B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (de) 1999-10-26 2000-10-11 Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid

Publications (3)

Publication Number Publication Date
NO20021950D0 true NO20021950D0 (no) 2002-04-25
NO20021950L NO20021950L (no) 2002-04-25
NO328250B1 NO328250B1 (no) 2010-01-18

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021950A NO328250B1 (no) 1999-10-26 2002-04-25 Fremgangsmate for fremstilling av N-(4,5-bis-metansulfonyl-2-metylbenzoyl)-guanidin-hydroklorid

Country Status (25)

Country Link
US (1) US6673968B1 (no)
EP (1) EP1224166B1 (no)
JP (1) JP4969750B2 (no)
KR (1) KR100699571B1 (no)
CN (1) CN1202078C (no)
AT (1) ATE250026T1 (no)
AU (1) AU782471B2 (no)
BR (1) BR0015022A (no)
CA (1) CA2388915C (no)
CZ (1) CZ299201B6 (no)
DE (2) DE19951418A1 (no)
DK (1) DK1224166T3 (no)
ES (1) ES2204712T3 (no)
HU (1) HU228634B1 (no)
MX (1) MXPA02004144A (no)
MY (1) MY122651A (no)
NO (1) NO328250B1 (no)
PL (1) PL199010B1 (no)
PT (1) PT1224166E (no)
RU (1) RU2276134C2 (no)
SI (1) SI1224166T1 (no)
SK (1) SK286603B6 (no)
UA (1) UA73329C2 (no)
WO (1) WO2001030750A1 (no)
ZA (1) ZA200204119B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
WO2004099125A1 (de) * 2003-05-06 2004-11-18 Merck Patent Gmbh Verfahren zur kristallisation von guanidinium-salzen
AU2009243749B2 (en) * 2008-05-09 2013-11-21 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
CN105358530A (zh) * 2013-06-10 2016-02-24 美国安进公司 制备mdm2抑制剂的方法及其结晶形式
EP3159347A4 (en) * 2014-06-23 2018-01-24 Nissan Chemical Industries, Ltd. Method for producing sulfonyl-bond-containing silane compound
CN117304079A (zh) 2016-02-08 2023-12-29 默克专利股份有限公司 N-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐酸盐和n-(4,5-双甲磺酰基-2-甲基苯甲酰基)胍盐的结晶变体
EP3960165A1 (en) * 2020-08-25 2022-03-02 Fondation EspeRare Nhe-1 inhibitors for the treatment of coronavirus infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
DK0723956T3 (da) * 1995-01-30 2000-04-17 Hoechst Ag Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19526381A1 (de) * 1995-07-19 1997-01-23 Hoechst Ag 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
PL355149A1 (en) 2004-04-05
HUP0203132A3 (en) 2004-12-28
MY122651A (en) 2006-04-29
JP4969750B2 (ja) 2012-07-04
ATE250026T1 (de) 2003-10-15
RU2276134C2 (ru) 2006-05-10
PT1224166E (pt) 2004-02-27
JP2003512451A (ja) 2003-04-02
KR20020044572A (ko) 2002-06-15
CN1382120A (zh) 2002-11-27
DE50003759D1 (de) 2003-10-23
HK1051358A1 (en) 2003-08-01
CA2388915A1 (en) 2001-05-03
HUP0203132A2 (hu) 2003-01-28
PL199010B1 (pl) 2008-08-29
ES2204712T3 (es) 2004-05-01
DK1224166T3 (da) 2004-01-05
US6673968B1 (en) 2004-01-06
SK5462002A3 (en) 2002-10-08
AU782471B2 (en) 2005-08-04
DE19951418A1 (de) 2001-05-03
EP1224166B1 (de) 2003-09-17
AU1136101A (en) 2001-05-08
BR0015022A (pt) 2002-06-18
CA2388915C (en) 2009-12-15
SI1224166T1 (en) 2004-04-30
CZ299201B6 (cs) 2008-05-14
CZ20021354A3 (cs) 2002-09-11
UA73329C2 (uk) 2005-07-15
HU228634B1 (en) 2013-04-29
MXPA02004144A (es) 2006-01-12
KR100699571B1 (ko) 2007-03-23
SK286603B6 (sk) 2009-02-05
NO20021950L (no) 2002-04-25
WO2001030750A1 (de) 2001-05-03
NO328250B1 (no) 2010-01-18
ZA200204119B (en) 2003-10-29
CN1202078C (zh) 2005-05-18
EP1224166A1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
EP1442016A4 (en) 1H-INDOLDERIVATE AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
MY119820A (en) Guanidine mimics as factor xa inhibitors
DK0850221T3 (da) Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister
DK1200418T3 (da) Nematodicide trifluorbutener
BR0304213A (pt) Processo para a sìntese industrial de ranelato de estrÈncio e os seus hidratos
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
CY1108224T1 (el) Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα
NO20021950L (no) Fremgangsmåte for fremstilling av N-(4,5-bis-metansulfonyl-2- metylbenzoyl)-guanidin-hydroklorid
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE315026T1 (de) Amlodipin-hemimaleat
ATE223405T1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ATE427934T1 (de) Nicht-peptidische brs-3-agonisten
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
AR026231A1 (es) Proceso para preparar clorhidrato de n-(4,5-bis-metansulfonil-2-metilbenzoil)-guanidina
NO20021821L (no) Natrium-hydrogen utvekslingstype 1 inhibitor krystaller
NO20030606D0 (no) Modifisert gj¶r og anvendelser derav, n¶rmere bestemt for fremstilling avsteroidderivater
ITMI920720A1 (it) Forma cristallina dell'endo-3-etil-2, 3-diidro-n-(8-metil-8-azabiciclo (3. 2. 1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees